Peter A. Prieto

9.2k total citations
43 papers, 1.1k citations indexed

About

Peter A. Prieto is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Peter A. Prieto has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Peter A. Prieto's work include Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (9 papers). Peter A. Prieto is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (9 papers). Peter A. Prieto collaborates with scholars based in United States, Spain and Malaysia. Peter A. Prieto's co-authors include Steven A. Rosenberg, Richard M. Sherry, Udai S. Kammula, Giao Q. Phan, Donald E. White, Marybeth S. Hughes, James Chih‐Hsin Yang, Catherine Lévy, John R. Wunderlich and Mark E. Dudley and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Peter A. Prieto

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter A. Prieto United States	13	828	659	233	102	89	43	1.1k
Zipei Feng United States	14	692 0.8×	516 0.8×	276 1.2×	48 0.5×	51 0.6×	36	1.0k
Eva Ellebæk Denmark	21	1.2k 1.4×	1.0k 1.5×	392 1.7×	146 1.4×	37 0.4×	71	1.6k
Heidi Braumüller Germany	16	543 0.7×	908 1.4×	266 1.1×	53 0.5×	93 1.0×	27	1.3k
Sofia Farkona Canada	8	517 0.6×	444 0.7×	284 1.2×	66 0.6×	54 0.6×	13	983
Nana-Ama A.S. Anang United States	4	973 1.2×	762 1.2×	223 1.0×	33 0.3×	50 0.6×	6	1.2k
Jennifer Baker United Kingdom	3	681 0.8×	1.1k 1.7×	155 0.7×	131 1.3×	47 0.5×	5	1.5k
Anna Kwilas United States	16	587 0.7×	457 0.7×	240 1.0×	95 0.9×	53 0.6×	24	969
Christiane Meyer Germany	6	942 1.1×	1.0k 1.6×	247 1.1×	32 0.3×	52 0.6×	8	1.4k
Richard Meagher United States	17	419 0.5×	458 0.7×	207 0.9×	81 0.8×	53 0.6×	44	1.0k
Aurélie Durgeau France	7	661 0.8×	776 1.2×	181 0.8×	33 0.3×	37 0.4×	7	1.0k

Countries citing papers authored by Peter A. Prieto

Since Specialization

Citations

This map shows the geographic impact of Peter A. Prieto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Prieto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Prieto more than expected).

Fields of papers citing papers by Peter A. Prieto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Prieto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Prieto. The network helps show where Peter A. Prieto may publish in the future.

Co-authorship network of co-authors of Peter A. Prieto

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Prieto. A scholar is included among the top collaborators of Peter A. Prieto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Prieto. Peter A. Prieto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prieto, Peter A., Laura K. Ferris, & Michael Guenther. (2025). Comparing Two Gene Expression Profile Tests to Standard of Care for Identifying Patients With Cutaneous Melanoma at Low Risk of Sentinel Lymph Node Positivity. Cancer Diagnosis & Prognosis. 5(3). 261–267. 1 indexed citations

Patel, Sapna P., Anastasios Dimou, Adrienne I. Victor, et al.. (2024). Safety and efficacy of first-in-class CXCR1/2 inhibitor SX-682 in combination with pembrolizumab (pem) in patients (pts) with metastatic melanoma (mMEL) with disease progression on anti–PD-1 therapy.. Journal of Clinical Oncology. 42(16_suppl). 9508–9508. 10 indexed citations

Escandón, Joseph M., Howard N. Langstein, Jessica C. Gooch, et al.. (2024). Single versus Double Drainage for Immediate Two-Stage Implant-Based Breast Reconstruction: A Propensity Score-Matched Analysis. Aesthetic Plastic Surgery. 48(17). 3304–3316. 1 indexed citations

Baek, Jihye, Shuyang Qin, Peter A. Prieto, & Kevin J. Parker. (2023). H-Scan Discrimination for Tumor Microenvironmental Heterogeneity in Melanoma. Ultrasound in Medicine & Biology. 50(2). 268–276. 1 indexed citations

Escandón, Joseph M., Anna Weiss, Howard N. Langstein, et al.. (2023). Prepectoral versus subpectoral two-stage implant-based breast reconstruction: U.S. medical center experience and narrative review. Annals of Translational Medicine. 11(12). 411–411. 6 indexed citations

Escandón, Joseph M., Jessica C. Gooch, Peter A. Prieto, et al.. (2022). Subpectoral versus prepectoral two-stage breast reconstruction: A propensity score-matched analysis of 30-day morbidity and long-term outcomes. Journal of Plastic Reconstructive & Aesthetic Surgery. 76. 76–87. 16 indexed citations

Jackson, Katherine M., Luis I. Ruffolo, Shuyang Qin, et al.. (2021). Picomets: Assessing single and few cell metastases in melanoma sentinel lymph node biopsies. Surgery. 170(3). 857–862. 1 indexed citations

Prieto, Peter A., et al.. (2021). COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma. The Lancet Oncology. 22(6). e281–e281. 7 indexed citations

Mills, Bradley N., Kelli A. Connolly, Jian Ye, et al.. (2019). Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment. Cell Reports. 29(2). 406–421.e5. 60 indexed citations

10.

Mooradian, Meghan J., Alexandre Reuben, Peter A. Prieto, et al.. (2018). A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma. OncoImmunology. 7(5). e1423172–e1423172. 20 indexed citations

11.

Gopalakrishnan, Vancheswaran, Christine N. Spencer, Alexandre Reuben, et al.. (2017). Association of diversity and composition of the gut microbiome with differential responses to PD-1 based therapy in patients with metastatic melanoma.. Journal of Clinical Oncology. 35(7_suppl). 2–2. 15 indexed citations

12.

Prieto, Peter A., Alexandre Reuben, Zachary A. Cooper, & Jennifer A. Wargo. (2016). Targeted Therapies Combined With Immune Checkpoint Therapy. The Cancer Journal. 22(2). 138–146. 29 indexed citations

13.

Christakis, Ioannis, Angelica M. Silva, Joseph Nates, et al.. (2016). Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience. Surgery. 160(2). 377–383. 2 indexed citations

14.

Starker, Lee F., Peter A. Prieto, Hop S. Tran Cao, et al.. (2016). Endocrine incidentalomas. Current Problems in Surgery. 53(5). 219–246. 6 indexed citations

15.

Lebastchi, Amir H., Peter A. Prieto, Christopher Chen, & Felix Lui. (2013). Appendiceal endometriosis in a pregnant woman presenting with acute perforated appendicitis. Journal of Surgical Case Reports. 2013(12). rjt104–rjt104. 10 indexed citations

16.

Prieto, Peter A., James Chih‐Hsin Yang, Richard M. Sherry, et al.. (2012). CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma. Clinical Cancer Research. 18(7). 2039–2047. 369 indexed citations

17.

Langan, Russell C., R. Taylor Ripley, Jeremy L. Davis, et al.. (2012). Liver Directed Therapy for Renal Cell Carcinoma. Journal of Cancer. 3. 184–190. 22 indexed citations

18.

Langan, Russell C., Peter A. Prieto, Richard M. Sherry, et al.. (2011). Assessment of Ovarian Function After Preparative Chemotherapy and Total Body Radiation for Adoptive Cell Therapy. Journal of Immunotherapy. 34(4). 397–402. 16 indexed citations

19.

Dudley, Mark E., Colin Gross, Michelle M. Langhan, et al.. (2010). CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma. Clinical Cancer Research. 16(24). 6122–6131. 245 indexed citations

20.

Prieto, Peter A., et al.. (2010). Enrichment of CD8+ Cells From Melanoma Tumor-infiltrating Lymphocyte Cultures Reveals Tumor Reactivity for Use in Adoptive Cell Therapy. Journal of Immunotherapy. 33(5). 547–556. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact